Literature DB >> 1465273

Is gall bladder ejection fraction a reliable predictor of acalculous gall bladder disease?

G W Middleton1, J H Williams.   

Abstract

The use of quantitative 99Tcm-EHIDA imaging with cholecystokinin and the measurement of gall bladder ejection fraction in a prospective study of 89 patients with right upper quadrant pain is described. Correlation with surgical and histological findings and clinical follow-up suggests that gall bladder ejection fraction < or = 35% is a reliable and accurate indicator of acalculous gall bladder disease.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1465273     DOI: 10.1097/00006231-199212000-00007

Source DB:  PubMed          Journal:  Nucl Med Commun        ISSN: 0143-3636            Impact factor:   1.690


  6 in total

Review 1.  Clinical uses of gut peptides.

Authors:  J Geoghegan; T N Pappas
Journal:  Ann Surg       Date:  1997-02       Impact factor: 12.969

Review 2.  Cholecystectomy for biliary dyskinesia: how did we get there?

Authors:  Klaus Bielefeldt; Shreyas Saligram; Susan L Zickmund; Anwar Dudekula; Mojtaba Olyaee; Dhiraj Yadav
Journal:  Dig Dis Sci       Date:  2014-09-06       Impact factor: 3.199

3.  A requiem for the cholecystokinin provocation test?

Authors:  A Smythe; A W Majeed; M Fitzhenry; A G Johnson
Journal:  Gut       Date:  1998-10       Impact factor: 23.059

4.  Effect of nitric oxide on gallbladder motility in patients with acalculous biliary pain: a cholescintigraphic study.

Authors:  László Madácsy; Borbála Velosy; Attila Szepes; Zoltán Szilvássy; László Pávics; László Csernay; János Lonovics
Journal:  Dig Dis Sci       Date:  2002-09       Impact factor: 3.199

5.  Diagnostic stringency and healthcare needs in patients with biliary dyskinesia.

Authors:  Nitin Aggarwal; Klaus Bielefeldt
Journal:  Dig Dis Sci       Date:  2013-08-11       Impact factor: 3.199

6.  Chronic acalculous cholecystitis: changes in patient demographics and evaluation since the advent of laparoscopy.

Authors:  K Jones-Monahan; J C Gruenberg
Journal:  JSLS       Date:  1999 Jul-Sep       Impact factor: 2.172

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.